• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用调节性 T 细胞治疗狼疮和其他自身免疫性疾病。

Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.

机构信息

Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.

出版信息

Immunotherapy. 2009 May;1(3):385-401. doi: 10.2217/imt.09.2.

DOI:10.2217/imt.09.2
PMID:20635958
Abstract

Regulatory T cells (Tregs) maintain immunological homeostasis and prevent autoimmunity. The depletion or functional alteration of Tregs may lead to the development of autoimmune diseases. Tregs consist of different subpopulations of cells, of which CD4(+)CD25(+)Foxp3(+) cells are the most well characterized. However, CD8 Tregs also constitute a major cell population that has been shown to play an important role in autoimmune diseases. This review will discuss the role of Tregs in autoimmune diseases in general and specifically in systemic lupus erythematosus (SLE). SLE is a multisystem autoimmune disease characterized by the production of autoantibodies against nuclear components and by the deposition of immune complexes in the kidneys as well as in other organs. Abnormalities in Tregs were reported in SLE patients and in animal models of the disease. Current treatment of SLE is based on immunosuppressive drugs that are nonspecific and may cause adverse effects. Therefore, the development of novel, specific, side effect-free therapeutic means that will induce functional Tregs is a most desirable goal. Our group and others have designed and utilized tolerogenic peptides that ameliorate SLE manifestations in murine models. Here, we demonstrate the role of CD4 and CD8 Tregs, as well as the interaction between the two subsets of cells and the mechanism of action of the tolerogenic peptides. We also discuss their therapeutic potential for the treatment of SLE.

摘要

调节性 T 细胞(Tregs)维持着免疫稳态,防止自身免疫。Tregs 的耗竭或功能改变可能导致自身免疫性疾病的发生。Tregs 由不同的细胞亚群组成,其中 CD4(+)CD25(+)Foxp3(+)细胞是最具特征的。然而,CD8 Tregs 也是一个主要的细胞群体,已经证明它在自身免疫性疾病中发挥着重要作用。本综述将讨论 Tregs 在一般自身免疫性疾病中的作用,特别是在系统性红斑狼疮(SLE)中的作用。SLE 是一种多系统自身免疫性疾病,其特征是产生针对核成分的自身抗体,并在肾脏以及其他器官中沉积免疫复合物。SLE 患者和疾病动物模型中报告了 Tregs 的异常。目前 SLE 的治疗基于免疫抑制药物,但这些药物是非特异性的,可能会引起不良反应。因此,开发新型、特异、无副作用的诱导功能性 Tregs 的治疗手段是一个非常理想的目标。我们的研究小组和其他研究小组设计并利用了耐受原性肽,这些肽在小鼠模型中改善了 SLE 的表现。在这里,我们展示了 CD4 和 CD8 Tregs 的作用,以及这两个细胞亚群之间的相互作用以及耐受原性肽的作用机制。我们还讨论了它们在治疗 SLE 方面的治疗潜力。

相似文献

1
Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.利用调节性 T 细胞治疗狼疮和其他自身免疫性疾病。
Immunotherapy. 2009 May;1(3):385-401. doi: 10.2217/imt.09.2.
2
Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.Bcl-xL 在狼疮样小鼠经耐受肽治疗后功能性调节性 CD4 细胞的发育中是必需的。
J Autoimmun. 2010 Mar;34(2):87-95. doi: 10.1016/j.jaut.2009.06.002. Epub 2009 Jul 12.
3
CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.人类红斑狼疮中的CD4(+)CD25(+)调节性T细胞
Arch Dermatol Res. 2009 Jan;301(1):71-81. doi: 10.1007/s00403-008-0891-9. Epub 2008 Nov 5.
4
Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.体外转化生长因子-β1诱导的CD4+CD25+调节性T细胞可逆转并预防小鼠慢性移植物抗宿主病的狼疮样综合征。
Br J Dermatol. 2008 Jun;158(6):1197-209. doi: 10.1111/j.1365-2133.2008.08555.x. Epub 2008 Apr 10.
5
Analysis of FOXP3 regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus.系统性红斑狼疮患者外周血和组织中FOXP3调节性T细胞亚群的分析
Immunol Res. 2017 Apr;65(2):551-563. doi: 10.1007/s12026-017-8904-4.
6
Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.系统性红斑狼疮中CD4(+) FoxP3(+)调节性T细胞亚群的稳态改变
Immunology. 2009 Jun;127(2):196-205. doi: 10.1111/j.1365-2567.2008.02937.x. Epub 2008 Sep 16.
7
CD4(+)FoxP3(+) regulatory T-cells in human systemic lupus erythematosus.人类系统性红斑狼疮中的 CD4(+)FoxP3(+) 调节性 T 细胞。
J Formos Med Assoc. 2012 Sep;111(9):465-70. doi: 10.1016/j.jfma.2012.05.013. Epub 2012 Aug 28.
8
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression.用耐受性肽hCDR1(依德肽)治疗狼疮患者:基因表达的免疫调节
J Autoimmun. 2009 Aug;33(1):77-82. doi: 10.1016/j.jaut.2009.03.009. Epub 2009 Apr 5.
9
Regulatory T cells in systemic lupus erythematosus.系统性红斑狼疮中的调节性T细胞。
Eur J Immunol. 2015 Feb;45(2):344-55. doi: 10.1002/eji.201344280. Epub 2014 Dec 15.
10
Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells.系统性红斑狼疮的发病机制研究进展——以调节性 T 细胞为例
J Autoimmun. 2010 Nov;35(3):269-75. doi: 10.1016/j.jaut.2010.06.018. Epub 2010 Jul 16.

引用本文的文献

1
Inhibition of IL-17 ameliorates systemic lupus erythematosus in Roquin mice through regulating the balance of TFH cells, GC B cells, Treg and Breg.抑制白介素-17 通过调节滤泡辅助性 T 细胞、生发中心 B 细胞、T 调节细胞和 B 调节细胞的平衡改善 Roquin 小鼠的系统性红斑狼疮。
Sci Rep. 2019 Mar 26;9(1):5227. doi: 10.1038/s41598-019-41534-1.
2
Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF).在慢性肝衰竭基础上发生的急性肝衰竭患者外周血 CD4(+)CD25(+)调节性 T 细胞(Tregs)表型及临床意义。
J Transl Med. 2012 Sep 15;10:193. doi: 10.1186/1479-5876-10-193.
3
Regulatory T-cell-associated cytokines in systemic lupus erythematosus.
系统性红斑狼疮中与调节性T细胞相关的细胞因子
J Biomed Biotechnol. 2011;2011:463412. doi: 10.1155/2011/463412. Epub 2011 Dec 18.
4
Tolerogenic dendritic cells and their potential applications.耐受原性树突状细胞及其潜在应用。
Immunology. 2011 Mar;132(3):307-14. doi: 10.1111/j.1365-2567.2010.03396.x. Epub 2011 Jan 5.